Figure five: Conolidine is antinociceptive in visceral, tonic and persistent soreness products and is also existing at micromolar degrees in the brain immediately after systemic injection.Conolidine CONOCB2™ fundamentally is effective by developing a barrier involving the opioid receptors from the brain and the "scavenger" receptors in the body,